DXS International (AQSE:DXSP) Market Cap: £0.80 Mil (As of Jul. 01, 2026)


What is DXS International Market Cap?

DXS International AQSE:DXSP Market Cap is £0.80 Mil as of Jul. 01, 2026. The stock has 2 warning signs investors should review. Among 695 Healthcare Providers & Services companies, DXS International ranks worse than 97.7% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). DXS International's share price for the quarter that ended in Apr. 2025 was £0.0225. DXS International's Shares Outstanding (EOP) for the quarter that ended in Apr. 2025 was 64.02 Mil. Therefore, DXS International's market cap for the quarter that ended in Apr. 2025 was £1.44 Mil.

DXS International's quarterly market cap declined from Apr. 2023 (£2.17 Mil) to Apr. 2024 (£0.86 Mil) but then increased from Apr. 2024 (£0.86 Mil) to Apr. 2025 (£1.44 Mil).

DXS International's annual market cap declined from Apr. 2023 (£2.17 Mil) to Apr. 2024 (£0.86 Mil) but then increased from Apr. 2024 (£0.86 Mil) to Apr. 2025 (£1.44 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. DXS International's Enterprise Value for Today is £0.84 Mil.


DXS International  (AQSE:DXSP) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


DXS International Market Cap Related Terms


DXS International Market Cap Historical Data

* Premium members only.

The historical data trend for DXS International's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

DXS International Market Cap Chart

DXS International Annual Data
Trend Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only 4.34 5.55 2.17 0.86 1.44

DXS International Semi-Annual Data
Apr15 Apr16 Apr17 Apr18 Apr19 Apr20 Apr21 Apr22 Apr23 Apr24 Apr25
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only 4.34 5.55 2.17 0.86 1.44

AQSE:DXSP vs VEEV, BTSG, TEM: Market Cap Comparison

For the Health Information Services subindustry, DXS International's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


DXS International Market Cap vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, DXS International's Market Cap distribution charts can be found below:

* The bar in red indicates where DXS International's Market Cap falls into.



DXS International Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

DXS International's Market Cap for the fiscal year that ended in Apr. 2025 is calculated as

Market Cap (A: Apr. 2025 )=Share Price (A: Apr. 2025 )*Shares Outstanding (EOP) (A: Apr. 2025 )
=£0.0225*64.022
=£1.44

DXS International's Market Cap for the quarter that ended in Apr. 2025 is calculated as

Market Cap (Q: Apr. 2025 )=Share Price (Q: Apr. 2025 )*Shares Outstanding (EOP) (Q: Apr. 2025 )
=£0.0225*64.022
=£1.44

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of £0.80 Mil mean?
DXS International (AQSE:DXSP) has a Market Cap of £0.80 Mil as of Jul. 01, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on DXS International and its competitors. According to the industry distribution chart, DXS International ranks #679 out of 695 companies in the Healthcare Providers & Services industry, placing it in the top 97.7%.
Is DXS International's Market Cap too high?
DXS International's current Market Cap is £0.80 Mil. Based on the distribution chart, DXS International ranks #679 out of 695 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers.
How does DXS International's Market Cap compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, DXS International ranks #679 out of 695 companies for Market Cap. This places DXS International in the lower half of its industry. The industry median Market Cap is 95.72. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Healthcare Providers & Services company?
The median Market Cap among Healthcare Providers & Services companies is 95.72, based on 695 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on DXS International and its competitors. For the Healthcare Providers & Services industry, the median Market Cap is 95.72 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. DXS International's current Market Cap is £0.80 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is DXS International stock overvalued right now?
Based on GuruFocus' analysis, DXS International (AQSE:DXSP) is currently considered Possible Value Trap. The stock's GF Value™ is £0.02, compared to a current price of £0.01 — trading 37.5% below its estimated fair value. The current Market Cap is £0.80 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For DXS International (AQSE:DXSP), the current Market Cap is £0.80 Mil as of Jul. 01, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

DXS International Business Description

Address 119 Saint Mary’s Road, Market Harborough, London, Leicestershire, GBR, LE16 7DT
DXS International PLC is engaged in the development and distribution of clinical decision support systems for General Practitioners, nurses, and retail pharmacies in the United Kingdom and South Africa. Its commercial activities include licensing DXS products to various ICBs, offering e-detailing opportunities to the pharmaceutical industry and the UK primary care sector, and licensing its technology to healthcare publishers. The company's products include BestPathway and Point-of-Care ExpertCare.